Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
Farid Fata(Cornell University), Ephraim S. Casper(Cornell University), David Leffel(Yale University), David H. Ilson(Memorial Sloan Kettering Cancer Center), David G. Pfister(Memorial Sloan Kettering Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), David P. Kelsen(Memorial Sloan Kettering Cancer Center), Gary K. Schwartz(Baylor University Medical Center)
Cited by 388
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k